Opko Health Inc (OPK)

06:22 AM

The recent 5.1% gain must have brightened CEO Phillip Frost's week, OPKO Health, Inc.'s (NASDAQ:OPK) most bullish insider - simplywall.st

06:22 AM

12:17 PM

What analysts say about OPKO Health Inc. stockTurbocharged investment results - Autocar Professional

12:17 PM

Jul 23, 2025

OPKO Health’s (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX) - Yahoo Finance

Jul 23, 2025

Jul 23, 2025

Is OPKO Health Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

What drives OPKO Health Inc. stock priceSuperior stock selection - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

OPKO Health Inc. Stock Analysis and ForecastTremendous portfolio expansion - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

11 Best American Penny Stocks to Buy According to Analysts - Insider Monkey

Jul 22, 2025

Jul 21, 2025

Quote - OPKO Health, Inc.

Jul 21, 2025

Jul 18, 2025

How high can OPKO Health Inc. stock price go in 2025Predictable Return Stock Picks - beatles.ru

Jul 18, 2025

Jul 14, 2025

OPKO Health (NASDAQ:OPK) Stock Rating Upgraded by LADENBURG THALM/SH SH - MarketBeat

Jul 14, 2025

Jul 14, 2025

OPKO Health, Inc. (NASDAQ:OPK) Receives $2.75 Consensus Price Target from Analysts - MarketBeat

Jul 14, 2025

Jul 11, 2025

H.C. Wainwright Reiterates a Buy Rating on Opko Health (OPK), Keeps the PT at $3 - MSN

Jul 11, 2025

Jul 11, 2025

Opko Health (OPK) Has a New Rating from Ladenburg Thalmann & Co. - The Globe and Mail

Jul 11, 2025

Jul 11, 2025

Capital Advisors Inc. OK Increases Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jul 11, 2025

Jul 08, 2025

OPKO Health and Entera Bio Announce Abstract on PK/PD of - GlobeNewswire

Jul 08, 2025

Jul 08, 2025

OPKO Health and Entera Bio abstract selected for ESPEN Congress - StreetInsider

Jul 08, 2025

Jul 08, 2025

OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress - Yahoo Finance

Jul 08, 2025

Jul 08, 2025

Breakthrough: First-Ever Oral Tablet Could Replace Daily Injections for Short Bowel Syndrome Treatment - Stock Titan

Jul 08, 2025

Jul 04, 2025

Investor Network: OPKO Health, Inc. to Host Earnings Call - ACCESS Newswire

Jul 04, 2025

Jun 30, 2025

OPKO Health (OPK) to Present OPK-88006 Data at ENDO 2025 - MSN

Jun 30, 2025

Jun 30, 2025

OPKO Health's Russell 2000 Defensive Index Inclusion: A Catalyst for Strategic Revaluation - AInvest

Jun 30, 2025

Jun 29, 2025

The Next Wave in Obesity Treatment: OPKO's OPK-88006 and Its Dual-Format Strategy - AInvest

Jun 29, 2025

Jun 29, 2025

10 Best Healthcare Penny Stocks to Buy According to Analysts - Insider Monkey

Jun 29, 2025

Jun 25, 2025

OPKO and Entera to present data on oral obesity treatment at ENDO 2025 - Investing.com Nigeria

Jun 25, 2025

Jun 25, 2025

OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting - OPKO Health, Inc.

Jun 25, 2025

Jun 24, 2025

Piper Sandler Reiterates a Buy Rating on Opko Health (OPK) With a $3 PT - Yahoo Finance

Jun 24, 2025

Jun 23, 2025

13 Best Long-Term Penny Stocks to Buy According to Analysts - Insider Monkey

Jun 23, 2025

Jun 18, 2025

Shareholders in OPKO Health (NASDAQ:OPK) have lost 51%, as stock drops 6.5% this past week - simplywall.st

Jun 18, 2025

Jun 14, 2025

Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN

Jun 14, 2025

Jun 13, 2025

Bone Cancer Drugs Market Set to Witness Significant Growth - openPR.com

Jun 13, 2025

Jun 13, 2025

Bank of America Corp DE Has $855,000 Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat

Jun 13, 2025

Jun 11, 2025

OPKO Health: Strong Pipeline Of Drugs, But Not Rushing To Buy (NASDAQ:OPK) - Seeking Alpha

Jun 11, 2025